High-frequency oscillatory ventilation in adults: clinical considerations and management priorities.
Recently, there has been renewed interest in high-frequency oscillatory ventilation (HFOV) as a lung-protective strategy in adults. It limits overdistension and prevents cyclic collapse by maintaining end-expiratory lung volume. Studies have shown that HFOV is safely tolerated in the adult population and may offer more benefit if applied early in the course of disease. These findings have implications for clinicians as the use of HFOV may increase in the coming decade. Gas transport mechanisms, ventilator settings, patient monitoring, and clinical considerations for HFOV are substantially different from conventional mechanical ventilation. This article reviews management strategies and monitoring priorities currently recommended for management of adults receiving HFOV.
Rose
Louise
L
Critical Care Nursing, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Toronto, Ontario, Canada. louise.rose@utoronto.ca
D000328:Adult; D000336:Aerosols; D019317:Evidence-Based Medicine; D006612:High-Frequency Ventilation / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D017053:Infection Control; D008991:Monitoring, Physiologic; D019148:Neuromuscular Blockade; D013396:Suction; D015300:Ventilator Weaning
D000336:Aerosols; D006993:Hypnotics and Sedatives